Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,307 | 1,304 | 2,621 | 507 | 1,531 |
| Marketable Securities | 33 | 32 | 33 | 31 | 31 |
| Receivables | 31 | 36 | 49 | 23 | 31 |
| TOTAL | $1,620 | $1,626 | $2,749 | $633 | $1,655 |
| Non-Current Assets | |||||
| PPE Net | 2 | 2 | 2 | 1 | 1 |
| Intangibles | 47 | 48 | 51 | 48 | 50 |
| TOTAL | $49 | $49 | $52 | $50 | $52 |
| Total Assets | $1,669 | $1,675 | $2,801 | $682 | $1,707 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 111 | 201 | 727 | 652 | 370 |
| Accrued Expenses | 92 | 291 | N/A | N/A | N/A |
| TOTAL | $203 | $492 | $727 | $739 | $461 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $203 | $492 | $727 | $739 | $461 |
| Shareholders' Equity | |||||
| Common Shares | 31,306 | 28,906 | 29,631 | 25,745 | 26,142 |
| Retained earnings | -39,227 | -37,044 | -37,419 | -33,673 | -32,774 |
| Other shareholders' equity | 3,070 | 3,203 | 3,573 | 2,012 | 1,925 |
| TOTAL | $1,466 | $1,183 | $2,074 | $-57 | $1,246 |
| Total Liabilities And Equity | $1,669 | $1,675 | $2,801 | $682 | $1,707 |